What are the potential complications and management strategies for patients with complex medical histories, such as neurological disorders or critical illness, undergoing feeding jejunostomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Complications of Feeding Jejunostomy

Overview of Complication Rates

Feeding jejunostomy carries a substantial complication rate of approximately 20-22.5%, with major complications occurring in 4-4.7% of cases, and procedure-related mortality ranging from 0-1.4%. 1, 2, 3

The overall adverse event rate is significant, with the largest analysis of 307 jejunostomy attempts showing a 68% success rate and 22.5% experiencing adverse events. 1


Major Complications (Life-Threatening)

Surgical Emergencies

  • Bowel perforation (small bowel or colonic): Occurs in approximately 2-3% of cases and may require emergency laparotomy 1, 2, 3
  • Jejunal volvulus: A unique complication of direct jejunostomy, occurring in approximately 1% of cases, often requiring surgical intervention 1
  • Small bowel necrosis/ischemia: Reported in trauma patients, particularly with Witzel-type tubes 4, 3
  • Intraperitoneal leakage: Can lead to peritonitis and sepsis, occurring in 1-3% of cases 4, 2, 3

Hemorrhagic Complications

  • Severe bleeding (gastric or abdominal): Occurs in approximately 1% of cases 1

Infectious Complications

  • Abdominal wall abscess: Reported in endoscopy-guided procedures 1
  • Aspiration pneumonia: Particularly in neurological patients unable to protect airways, with incidence up to 20% 1, 4
  • Sepsis/peritonitis: Can result from peristomal infection or intraperitoneal contamination 1

Critical Pitfall: Major complications occur more frequently with larger Witzel-type tubes compared to needle catheter jejunostomy (p = 0.03), with procedure-related mortality of 1.4% in trauma patients. 3


Minor Complications (Non-Life-Threatening but Clinically Significant)

Mechanical Complications (Most Common)

  • Tube dislodgement: Occurs in 4-8.2% of cases, more frequent in neurological patients due to higher medication use 1, 2
  • Tube obstruction/clogging: Occurs in 8.2-10.9% of cases, especially with small-caliber tubes and inadequate flushing 1, 4, 2
  • Tube migration: Can occur with inadequate fixation 1, 4

Stoma-Related Complications

  • Peristomal infection: Occurs in 1-4.1% of cases 1, 2
  • Persistent pain at jejunal access site: Reported in 6-11% of minor complications 1
  • Pressure-induced jejunal mucosal ulcerations: Result from chronic tube pressure 1
  • Persistent enterocutaneous fistulas: Can occur after tube removal, particularly with direct jejunostomy 1
  • Leakage around tube site: Occurs in 1-2.7% of cases 4, 2

Gastrointestinal Complications

  • Diarrhea: Occurs in 2.3-6.8% of patients, may be related to formula type or administration rate 1, 4
  • Abdominal distension and cramping: Common with rapid infusion rates 1, 4
  • Nausea and vomiting: Can indicate feeding intolerance 1, 4
  • Constipation: May result from inadequate fluid intake or underlying disease 1

Metabolic Complications

  • Hyperglycemia: Occurs in up to 29% of patients 1, 4
  • Hypokalemia: Occurs in up to 50% of patients 4
  • Hypophosphatemia and hypomagnesemia: Risk factors for refeeding syndrome 1, 4
  • Electrolyte imbalances: Require close monitoring, especially in malnourished patients 1, 4
  • Refeeding syndrome: Potentially fatal if not monitored, particularly when initiating nutrition in malnourished patients 1

Management Strategies by Patient Population

Neurological Disorders (Stroke, Motor Neurone Disease, Parkinson's Disease)

Patient Selection: Jejunostomy should only be considered when dysphagia is expected to persist beyond 4-6 weeks and the patient has adequate gastrointestinal function. 1

Key Management Points:

  • Aspiration prevention: Elevate head of bed 30° or more during and for 30 minutes after feeding 1
  • Mechanical complications: Neurological patients have significantly more complications than cancer patients, primarily mechanical issues related to higher medication use 1
  • Tube selection: Use percutaneous tubes instead of nasal tubes for long-term needs (≥4-6 weeks) to reduce mechanical complications (Grade B recommendation) 1
  • Monitoring: Regular assessment for aspiration risk, as incidence can reach 20% in patients unable to protect airways 1

Special Consideration: For stroke patients, more than half will recover neurologic function within 4 months, making jejunostomy a valuable bridge therapy. 1

Critical Illness/ICU Patients

Timing of Placement: Initiate within 24-48 hours of ICU admission if hemodynamically stable and enteral nutrition is indicated. 5, 6

Key Management Points:

  • Energy provision: Limit to 20-25 kcal/kg/day during acute phase to avoid overfeeding, which worsens outcomes 5, 6
  • Feeding protocol: Start at low flow rates (10-20 ml/h) and increase gradually over 5-7 days to target 5, 7, 6
  • Formula selection: Use commercial formula feeds rather than blenderized diets due to consistent nutritional content, lower tube clogging risk, and reduced microbial contamination 1, 5
  • Monitoring: Strict electrolyte and phosphorus monitoring for refeeding syndrome, especially in malnourished patients 1, 6
  • Gastric residuals: High residuals should prompt intervention rather than abandonment of enteral nutrition 6

Critical Pitfall: Overfeeding during acute phase (>25 kcal/kg/day) may worsen outcomes and increase infectious complications. 5, 6

Complex Medical Histories (Multiple Comorbidities)

Contraindications to Consider:

  • Gastro-oesophageal reflux (relative contraindication) 1
  • Previous gastric surgery 1
  • Ascites 1
  • Gastric outlet obstruction 1
  • Small bowel motility problems 1
  • Coagulopathy 1
  • Peritoneal dialysis 1

Key Management Points:

  • Tube fixation: Use multiple jejunopexy devices during placement to decrease risk of jejunal volvulus 1
  • Tube size: Smaller needle catheter jejunostomy appears safer than larger Witzel-type tubes, particularly in trauma patients (p = 0.03) 3
  • Tract establishment: Leave surgical jejunostomies in place for 3-5 weeks even if feeding stops, to allow tract formation and purse string suture dissolution 1

Prevention and Management Algorithm

Preventing Tube Obstruction

  1. Flush with water before and after every feed or medication 1
  2. Use liquid medications (elixirs or suspensions) rather than crushed tablets 1
  3. Avoid hyperosmolar drugs, crushed tablets, potassium, iron supplements, and sucralfate through the tube 1
  4. If obstruction occurs:
    • First attempt: Flush with warm water 1
    • Second attempt: Use alkaline solution of pancreatic enzymes 1
    • Avoid carbonated drinks due to sugar content enhancing bacterial contamination risk 1
    • Last resort: Pass soft guidewire or use commercial tube declogger (expert only) 1

Managing Aspiration Risk

  1. Elevate head of bed 30° or more during and for 30 minutes after feeding 1
  2. Consider post-pyloric feeding if aspiration occurs despite precautions 1
  3. Administer motility agents to promote gastric emptying if indicated 1
  4. Monitor for silent aspiration in patients with impaired consciousness or poor gag reflexes 1

Managing Gastrointestinal Intolerance

  1. Nausea/bloating: Reduce infusion rate, consider prokinetic agents 1
  2. Diarrhea: Evaluate for Clostridium difficile, medication side effects, formula osmolality 1
  3. High gastric residuals: Do not automatically stop feeds; consider prokinetic agents and continued monitoring 6

Managing Metabolic Complications

  1. Monitor plasma electrolytes and phosphorus strictly, especially when initiating nutrition in malnourished patients 1, 6
  2. Screen for refeeding syndrome risk factors: prolonged fasting, significant weight loss, low baseline electrolytes 1
  3. Correct electrolyte abnormalities before advancing feeding rate 1

When to Avoid Jejunostomy

Absolute Contraindications:

  • Mesenteric ischemia 6
  • Mechanical bowel obstruction 6
  • Non-functioning gastrointestinal tract 6

Situations Where Risk Outweighs Benefit:

  • End-stage incurable cancer: Gastrostomy/jejunostomy tubes should not be placed routinely, as enteral access may actually increase complications 1
  • Advanced dementia: No consistent benefit demonstrated; 63% of patients never experience hunger or thirst without intervention 1
  • Expected short-term use: Jejunostomy should only be performed for patients with clear indications and high potential for long-term use (>4-6 weeks) 1, 8

Post-Discharge Care Requirements

Essential Elements (Grade B recommendation):

  • Adequate training of patient/caregiver in pump use, infection control, and stoma care before discharge 1
  • Continuity of care: HEN team should provide adequate follow-up to decrease complications and rehospitalizations 1
  • Written protocols: Hospitals should follow standardized discharge protocols 1
  • Contact information: Patient/carer should have list of expert contacts 1
  • Community coordination: Full liaison with district nurses, community dietitians, and GPs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Jejunostomy: techniques, indications, and complications.

World journal of surgery, 1999

Guideline

Nasogastric Feeding in ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Enteral Nutrition in ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Administration of JOURNAVZ with Jejunal Tube Feeds

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Jejunostomy. A rarely indicated procedure.

Archives of surgery (Chicago, Ill. : 1960), 1986

Related Questions

What are the indications for feeding jejunostomy in patients with conditions such as severe dysphagia, esophageal obstruction, or neurological disorders affecting swallowing, including those with head and neck cancers, amyotrophic lateral sclerosis (ALS), or severe stroke?
Why is a jejunojejunostomy (intestinal bypass surgery) issue not the primary concern for the patient's elevated white blood cell (WBC) count?
What are the recommended techniques for feeding jejunostomy (percutaneous endoscopic jejunostomy - PEJ)?
Why is jejunojejunostomy (jejunum to jejunum connection) often performed with gastrojejunostomy (stomach to jejunum connection)?
Can a laxative be administered through a jejunostomy (jejunum ostomy) tube?
What is the current best practice for treating a toddler's fracture in a toddler?
What are alternative medication options for managing agitation in an elderly hospice patient with rapid decline, potential impending NPO (nothing by mouth) status, and multiple episodes of agitation per day?
What is the recommended treatment approach for insomnia in geriatric patients with dementia using doxepin (tricyclic antidepressant)?
What is the likely diagnosis and management for a 5-year-old patient, taking levetiracetam (levetiracetam), who experienced a possible seizure or syncopal event triggered by overheating, characterized by tonic posturing, pallor, and bradycardia, with subsequent weakness and EEG findings of rhythmic intermittent delta-theta slowing?
What are the considerations for starting naltrexone (opioid receptor antagonist) therapy in a patient with Timothy syndrome?
How reliable are negative treponemal and Rapid Plasma Reagin (RPR) tests in ruling out syphilis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.